Integrating biology, frailty, and patient values: The 5M framework for older adults with multiple myeloma
Clinical Hematology International · 03.11.2026 · 8 (3)
DOI: 10.46989/001c.171785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Hematology International, online erschienen am 03.11.2026. Verfasst von Atsushi Isoda. Beteiligte Einrichtung: Department of Hematology, Iryohojin Hoshiiin, Maebashi, Gunma, Japan. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Multiple myeloma (MM) predominantly affects older adults, in whom frailty, comorbidities, and psychosocial factors complicate treatment decision-making. Existing tools, including the International Myeloma Working Group (IMWG) frailty score and comprehensive geriatric assessment (CGA), provide valuable insights but do not offer a structured approach that integrates disease biology, treatment feasibility, and patient values. To address this gap, we developed the 5M Framework for Older Adults with Multiple Myeloma (5M-OMM), a five-domain model that supports stepwise, multidisciplinary decision-making. The framework first defines a biologically informed strategy aligned with patient priorities and then incorporates functional, psychological, and social factors to refine the treatment plan. Application to representative clinical cases illustrates how selecting initial therapy according to disease biology and patient priorities, followed by adaptation to frailty and comorbidity burden, can improve feasibility and reduce the risk of undertreatment when frailty tools are used in isolation. The 5M-OMM complements existing geriatric oncology approaches by providing a practical structure for reassessment and multidisciplinary shared decision-making in older adults with MM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Iryohojin Hoshiiin, Maebashi, Gunma, Japan.
ORCID-Profile: Atsushi Isoda
Zitieren
APA
Isoda, A. (2026). Integrating biology, frailty, and patient values: The 5M framework for older adults with multiple myeloma. Clinical Hematology International, 8(3). https://doi.org/10.46989/001c.171785
Vancouver
Isoda A. Integrating biology, frailty, and patient values: The 5M framework for older adults with multiple myeloma. Clinical Hematology International. 2026;8(3). doi:10.46989/001c.171785
BibTeX
@article{Isoda2026,
author = {Isoda, Atsushi},
title = {Integrating biology, frailty, and patient values: The 5M framework for older adults with multiple myeloma},
journal = {Clinical Hematology International},
year = {2026},
volume = {8},
number = {3},
doi = {10.46989/001c.171785}
}
EUVIMED